Unicorn Capital Partners

Unicorn Capital Partners is a venture capital investment that manages a newly raised fund of Rub 4,5B (~$65M), co-invested by the Russian Government. The company focused on Series A and B investments in breakthrough therapeutics, diagnostics, devices, and medical IT sectors, addressing unmet medical needs in Russia.

Maxim Gorbachev

Managing Partner

2 past transactions

Tezign

Series C in 2021
Tezign is the Content + AI unicorn focused on generative AI for enterprise content. Founded in 2015, Tezign aims to build the digital infrastructure of content experience, helping global leading enterprises produce, manage, distribute, and analyze content more efficiently and of higher quality with GenAI technology. Tezign has been trusted by over 200 leading enterprises including Alibaba, Unilever, Procter & Gamble, Novartis Pharmaceuticals, L'Oréal, Shiseido, Adidas, Chow Tai Fook, Caterpillar, Lenovo, Aptar, Bosch, Stanley Black & Decker, McDonald's, Starbucks, Audi, Porsche, CICC. It has produced more than 150,000 content assets and formed a one hundred million level content asset management scale. Tezign's content ecosystem has gathered more than 100,000 content creators.

Botkin.AI

Series B in 2020
Botkin.AI is a software-based platform for medical image processing and analysis based on artificial intelligence. The Company provides AI for analyzing radiograms and diagnosing the risk of tumors. The solution is based on deep machine learning. Botkin.AI significantly expands the radiologists’ ability to diagnose tumors and speeds up the processing of an increased flow of the patient’s clinical data without losing the quality of medical conclusions. It was founded in 2015 and is based in Moscow, Russian.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.